Open AccessAzithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients
Author(s) -
Ajay Sheshadri,
Rima M. Saliba,
Badar Patel,
Tahreem Ahmed,
Luis C. Bueno,
Muhammad H. Arain,
Rohtesh S. Mehta,
Uday Popat,
Chitra Hosing,
Gabriela Rondón,
Lara Bashoura,
Burton F. Dickey,
Richard E. Champlin,
Amin M. Alousi
Publication year - 2020
Publication title -
bone marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.609
H-Index - 127
eISSN - 1476-5365
pISSN - 0268-3369
DOI - 10.1038/s41409-020-01073-0
Subject(s) - medicine , anti thymocyte globulin , azithromycin , hematopoietic cell , globulin , immunology , haematopoiesis , hematopoietic stem cell transplantation , transplantation , stem cell , antibiotics , genetics , microbiology and biotechnology , biology